10x Genomics, Inc.
TXG NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
-0.24
EPS Actual
-0.14
Revenue Est.
$146.7M
Revenue Actual
$151M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.27
Revenue Est.
$147.2M
Company Overview
10x Genomics, Inc. (ticker TXG) is listed on NASDAQ with a market cap of about $8.27B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), After-market, with consensus EPS of -0.27. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 15, 2023 → Aug 6, 2026
Feb 15, 2023Range: -0.53 ~ 0.28Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.24 | Above forecast↑-0.14 | $146.7M | $151M |
| May 7, 2026 | -- | -0.29 | Above forecast↑-0.10 | $146.4M | $150.8M |
| Feb 12, 2026 | -- | -0.19 | Above forecast↑-0.13 | $159.7M | $166M |
| Nov 6, 2025 | -- | -0.07 | Below forecast↓-0.22 | $142.5M | $149M |
| Aug 7, 2025 | -- | -0.35 | Above forecast↑0.28 | $139.5M | $172.9M |
| May 8, 2025 | -- | -0.45 | Above forecast↑-0.36 | $145.3M | $154.9M |
| Feb 12, 2025 | -- | -0.29 | Below forecast↓-0.40 | $165M | $165M |
| Oct 29, 2024 | -- | -0.34 | -0.30 | $153.3M | $151.7M |
| Aug 8, 2024 | -- | -0.47 | Above forecast↑-0.32 | $150.1M | $153.1M |
| Apr 30, 2024 | -- | -0.46 | -0.50 | $142.2M | $141M |
| Feb 15, 2024 | -- | -0.36 | -0.41 | $182.8M | $184M |
| Nov 2, 2023 | -- | -0.45 | -0.51 | $151.3M | $153.6M |
| Aug 3, 2023 | -- | -0.39 | Below forecast↓-0.53 | $140M | $146.8M |
| May 3, 2023 | -- | -0.38 | Below forecast↓-0.44 | $138.8M | $134.3M |
| Feb 15, 2023 | -- | -0.29 | Above forecast↑-0.15 | $148.2M | $156.2M |
Original Filings (SEC)
10-Q2026-08-07 ↗
8-K2026-08-06 ↗
8-K2026-06-08 ↗
10-Q2026-05-08 ↗
8-K2026-05-07 ↗
10-K2026-02-13 ↗
8-K2026-02-12 ↗
8-K2026-01-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
